Objective: We aimed to achieve accurate statistical modeling of a putative relationship between carotid endarterectomy (CEA) annual surgeon and hospital volume and in-hospital mortality.
Carotid endarterectomy (CEA) remains one of the most common vascular surgical procedures in the United States. More than 50 years after its implementation by Eastcott and Robb, CEA remains the "gold standard" treatment for carotid artery disease. [1] [2] [3] The predominance of this procedure has been established by numerous studies demonstrating its safety and efficacy. The North American Symptomatic Carotid Endarterectomy Trial (1991) 4 and The Asymptomatic Carotid Atherosclerosis Study (1995) 5 supported the superiority of the CEA over the best medical management of patients with Ն50% symptomatic or Ն60% asymptomatic carotid stenoses, respectively.
Despite the proven efficacy of this procedure, questions remain as to whether all patients have access to the high quality surgeons and hospitals reflected in these and other pivotal studies. Studies of other surgically treated diseases support the notion that "practice makes perfect": those surgeons or hospitals performing the greatest number of surgeries yearly provide the best outcomes. [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] Numerous studies of CEA have established tiers of surgeons or hospitals performing low-, middle-, and high-numbers of CEAs per year and demonstrated differences in outcomes among these strata. 15, [18] [19] [20] [21] [22] [23] [24] Using this evidence, practitioners and health policymakers have argued that higher volume surgeons and hospitals render superior CEA results to patients, leading to calls for regionalization of CEA care. [25] [26] [27] To date, investigators of the volume-outcome relationship for CEA surgery have arrived at their thresholds for high-, medium-, and low-volume surgeons and hospitals either empirically or based on quantiles. [18] [19] [20] [21] [22] 24, 28 While many authors have found a volume effect for CEA, their wide-ranging definitions for volume categories makes it difficult to effect definitive policy changes or for patients to know what annual surgical volume does make a difference to their outcome.
We hypothesized that we could establish evidenceguided volume guidelines for hospital and surgeon volume using standard statistical techniques. By allowing the data of 10 years of the Maryland hospital discharge database to drive the analysis, we hypothesized that we could find the best-supported volume categories for CEA. Furthermore, we hypothesized that a model including other covariates such as age, race, gender, and comorbidities would establish the relative contribution of surgeon and hospital volume compared with these other factors. Because of the state-specific nature of our dataset, our hypotheses focused on the effects of recent surgeon and hospital experience, rather than "lifetime" experience.
MATERIALS AND METHODS
The present study was a secondary data analysis of 10 years (1994) (1995) (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) of the Maryland Health Services Cost Review Commission (HSCRC) database. Established in 1971 by the Maryland legislature, this organization aims primarily to contain rising medical costs. In the process, the HSCRC collects extensive information on all patients and medical procedures occurring within the state of Maryland. We analyzed the HSCRC dataset over the abovementioned 10-year period, using a previously reported algorithm to identify 22,772 patients undergoing CEA. [29] [30] [31] Patients with all three of the following diagnoses were included: 1) International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) procedure code 38.12 (endarterectomy of the vessels of the head and neck other than intracranial vessels) in the primary coding position but not in any secondary position, and 2) Diagnosis-Related Group (DRG) 5 (extracranial vascular procedure), and 3) Diagnosis code 433.00 to 433.91 (occlusion/stenosis, precerebral artery). The accuracy of this algorithm was confirmed through a previously published chart review, in which the presence of all three of the abovementioned codes was required to achieve 100% correct identification of CEA patients. 29 Patients receiving CEA concurrently with another procedure, such as coronary artery bypass grafting, were not included in this analysis, based on the previous performance of the algorithm. We analyzed the relationship between in-hospital death and annual surgeon and hospital volume. Annual surgeon volume was defined by the total number of procedures performed by a surgeon for their total time within the dataset divided by the number of years the surgeon was included in the dataset. Thus a surgeon who was included in the dataset for only five years would have an average volume that could be compared with any other surgeon who was included for any amount of time between one and ten years.
Crude odds ratios of death were first determined by logistic regression for annual surgeon volume and annual hospital volume. Heterogeneity by calendar year was explored by performing the analysis within each year. Nonlinear relationships between death and average annual surgeon and hospital volume were explored by examining logit-transformed lowess smoothing functions. A lowess smoothing function facilitates visual inspection of the data as well as quantitative assessment by fitting a weighted linear least squares regression over small localized segments of the data. Thus a scatterplot of data is rendered more visually accessible by the superimposition of a smooth line that can reflect slope changes across the range of the explanatory variable. If the lowess smoothed line has a natural inflection point (ie visually noticeable change in the slope), the investigator can then elect to treat different ranges of the explanatory variable individually in the analysis, by allowing the slope to change over the range of the variable. In other words, an inflection point (known as a "knot" statistically) can be used to demarcate two different slopes in the regression. Since the outcome of our analysis was odds of death, we used a curve smoothed by log odds ("logit"). 32 Rough identification of spline knots from the plots was followed by using random effect models and inspecting likelihood of the data under each combination of spline knots. When various combinations of knots appear possible from preliminary visual inspection of the data, the investigator may wish to weigh the explanatory power of including all possible knots versus more parsimonious models including only a subset of knots. Random effects models allow each subject (each surgeon in this case) to have a different intercept such that minimal assumptions are made about correlations between surgeons. Consideration was given to other values around the knots initially identified, Ϯ5 CEAs per year. This exploration of values around the knots identified by visual inspection was done to ensure that the best value had been chosen in terms of its explanatory power. A functional form for age was similarly determined by inspection of logit transformed lowess smoothed plots.
Analysis proceeded similarly for looking at hospital volumes. Annual average hospital volume was defined analogously as for annual average surgeon volume: number of procedures performed in the hospital in the complete 10-year dataset, divided by the number of years the hospital was included in the dataset.
The effect of patient co-morbidity was determined through use of unweighted Charlson comorbidities. 33 The Charlson Index was developed in 1987 as a way to communicate the risk profile of a patient by pooling weighted values for selected conditions. The weights and chosen comorbidites were developed by Charlson et al using an inpatient cohort of 604 patients admitted to the medical service of New York Hospital. We chose to disregard the weights in the present study, instead using the number of Charlson comorbidities as identified by ICD-9-CM codes in the dataset, per Deyo. 34 The list of comorbidities is as follows: 33 Patients with Ն3 Charlson comorbidities were used as a reference in comparison with patients with one or two comorbidities for association with risk of death.
A marginal model with generalized estimating equations (GEE) was used to represent the population-average response as a function of covariates and to account for clustering in the data. Clustering was accounted for only at the surgeon level, not hospital.
All measures of statistical significance were based on ␣ ϭ 0.05. Stata SE, version 10, from Stata Corporation (College Station, Tex) was used for data analysis. The final model employed general estimating equations using exchangeable correlation.
RESULTS
From 1994-2003, CEA was performed on 22,772 patients in Maryland, in 47 hospitals by 442 surgeons. This sample consisted of 54.7% men and 45.3% women, ranging in age from 33-99 years (mean, 70.6 years). The vast majority of the patients were white (21,229 or 91.4%); 1,682 were black (7.2%). There were 123 in-hospital deaths (0.54%) over this 10-year period among those with surgeon identifiers.
Examination of the histogram of average annual surgeon volume demonstrates a strong predominance of lowvolume surgeons (Fig 1) . This distribution of CEAs among surgeons follows a roughly inverse power relationship, with 214 of the surgeons (48.42%) performing an average of only one CEA per year.
The crude odds ratio of death for the entire surgeon dataset was 0.9838, meaning that the odds of death decreased by an average of 0.0162 for each additional annual procedure.
The possibility of heterogeneity of volume effect by calendar year was considered. However, since the number of observations (deaths following CEA) per calendar year was small, it was not possible to detect heterogeneity if it did exist. For the interpretation of this study, we assumed homogenous effect of surgeon volume on death over calendar years.
Examination of the logit (log-odds) transformed lowess smoothed functions suggested three knots for surgeon volume: around five CEAs per year, 20 CEAs per year, and 35 CEAs per year. (Fig 2) . Using random effects models we examined log likelihoods of different models around these knots (i.e. 3, 4, 5, 15-25, 30-40, etc.) and found the highest log likelihood to be rendered by knots at 3 CEAs per year and 15 CEAs per year. Despite the suggestion of a knot around 35 CEAs per year, the P value for this knot was not significant. The lowess smoothed plot for patient age clearly suggested an inflection at 60 years, a value that was subsequently borne out by examination of ages grouped around 60 years. Patients over age 60 comprised 85.96% of the sample.
In analysis of hospital volume, a high proportion of low-volume hospitals was again noted in histogram analysis (Fig 3) . Examination of the logit transformed smooth curve suggested two splines at annual hospital volume of 25 CEAs per year and 130 CEAs per year (Fig 4) . Examination of values around 25 CEAs per year did not support inclusion of this knot in the model, but the knot at 130 CEAs per year was retained due to statistical significance.
This final model was used to predict the odds of inhospital death following CEA:
Logistic regression rendered the following point estimates, 95% confidence estimates and P values ( Table I) . As can be seen in the bolded values, surgeon volume of four to 15 CEAs per year was highly significant with respect to odds of death. For an increase in annual surgeon volume by one procedure per year, the odds of death decreased by .013) , or 0.055 decrease in the odds of death. The impact of each additional year of age on odds of death after CEA was U-shaped. For each additional year in age for those Յ60 years, the odds ratio per year of age was 0.936, but statistically non-significant (P ϭ .115). However, patients Ͼ60 years had an odds ratio of death of 1.058 per additional year of age (P Ͻ .0001). Finally, the number of Charlson comorbidities was highly significant, with each additional comorbidity adding significantly to the odds of death after CEA. Those with a single Charlson comorbidity had an odds ratio of death of 0.187 (P Ͻ .0001) compared with those with three or more comorbidities, while those with two comorbidities had an odds ratio of 0.362 (P Ͻ .0001) compared with the reference.
The inclusion of gender in the model did not change any of the inferences and was itself insignificant (P ϭ .7715). Female gender had an odds ratio of death of 0.948 compared with men when controlling for the covariates above. Non-white race (black and "other") had a higher odds of death after CEA than whites when controlling for other factors, but this relationship was non-significant.
Mortality rates for each volume group are shown in Table II , and cross-tabulation of mortality rates for subgroups of surgeon volume categories within hospital volume categories are shown in Table III . These tables include cumulative numbers of surgeons and CEAs over the 10-year study.
DISCUSSION
In this analysis of predictors of death for 22,772 CEAs with surgeon identifiers performed over 10 years in Maryland, the following covariates were found to be significant: 1) Each additional annual procedure for surgeons performing four to 15 CEAs per year (odds ratio 0.935, P ϭ .013); 2) Each additional annual procedure for hospitals performing Ͼ130 CEAs per year (odds ratio 0.945, P ϭ .013); 3) Each additional year of age Ͼ60 (odds ratio 1.058, P Ͻ .0001); 4) One Charlson comorbidity (odds ratio of 0.187 compared with three or more Charlson comorbidities, P Ͻ .0001); 5) Two Charlson comorbidities (odds ratio of 0.362 compared with three or more Charlson comorbidities, P Ͻ .0001). Odds ratios measure effect size, and describe the odds of an event occurring in one group to the odds of it occurring in another group. Generally speaking, odds represent the probability (p) of an event occurring to the probability of it not occurring: odds ϭ ( p ր 1 Ϫ p ). Thus an odds ratio of 1 indicates that an outcome (in-hospital death after CEA in this study) is equally likely between two groups. Logistic regression, employed here, provides odds ratios per unit change in the predictor. Thus an estimated odds ratio of 0.935 for CEA annual volume four to 15 means that a patient undergoing CEA by a surgeon performing five CEAs annually would have 0.935 the odds of in-hospital death compared with his odds of death should he have had a surgeon performing four CEAs annually, other covariates being equal. This difference may appear small at first glance, but magnifies as one compares slightly different annual surgeon volumes. To compare the odds of death for undergoing CEA by a surgeon performing nine CEAs per year to one performing four CEAs per year, one exponentiates the odds ratio: 0.935 5 ϭ 0.715. Therefore, when accounting for age, hospital annual volume, and comorbidities, the same patient undergoing CEA by a surgeon performing nine CEAs annually would be expected to have less than ¾ the risk of death compared with the risk should she undergo the surgery by a surgeon performing four CEAs annually.
The decrease in the odds of death per additional annual surgeon procedure differs depending on the volume range. Our study suggests that the difference per additional procedure is even more pronounced for annual surgeon volumes less than or equal to three. The odds ratio supported by our data for this volume range is 0.802, although this did not achieve statistical significance (P ϭ .351). A similar effect was seen in analysis of the effect of annual hospital volumes on the odds of death, but only in high volume centers. For the majority of hospitals in the database (those with annual CEA volume Յ130), the volume effect was exceedingly small and statistically nonsignificant per additional annual procedure (odds ratio 0.998, P ϭ .563). However, a statistically significant volume effect was seen in higher-volume centers, those performing Ͼ130 CEAs per year. In these higher volume centers, the odds ratio of death per additional procedure was 0.945, P ϭ.013. As before, this effect amplifies when considering large differences in annual volume within the range: a patient undergoing surgery at a center performing 150 CEAs per year would have an odds of death of 0.945 20 or 0.323 compared with undergoing surgery at a center that saw 130 CEAs per year. However, this finding should be interpreted with caution. There were very few centers with Ͼ130 annual CEAs included in this dataset and therefore these findings may not be generalizable. Observed differences in the odds of death could be due to centerspecific factors, rather than annual CEA volume. In spite of the suggestion of an inflection point around 25 CEAs per year on the hospital volume spline, no knots in this range were found to be significant. Thus the apparent rise in slope for the smoothed log odds of death in the low volume hospital range was not substantiated in likelihood ratio analysis. Although previous studies have found profound volume-outcome effects for hospital volume, they may not have controlled for surgeon volume as we did in this analysis. Similarly, our findings for high-volume surgeons are limited by the smaller number of providers in the upper ranges annual volume. Of note, there were 59 surgeons over the 10-year study (13.4% of our sample) in our category of Ͼ15 CEAs per year. Analysis of the effect on odds of death of an additional procedure per year for this group did not yield a statistically significant effect (P ϭ .485). It is possible that a larger sample size in this volume category could have rendered this effect significant. It is notable, however, that for both surgeons and hospitals, higher annual volume was always predictive of lower odds of death, even if the inference did not attain statistical significance. In no case did we find higher odds of death with higher annual CEA volume.
We found a U-shaped relationship for odds of death relative to age in this study. Each additional year of age in patients Յ60 years led to a decreased risk of death but did not attain statistical significance (odds ratio 0.936, P ϭ .115). However, in patients Ͼ60 years, each additional year contributed to the odds of death after CEA (odds ratio 1.058, P Ͻ .0001). We expect this U-shaped relationship is due to different risk profiles in the young undergoing CEA compared with those of advanced age. Young patients undergoing CEA may have risks that were not captured by our efforts to control for comorbidity in this analysis.
Finally, the presence of comorbidities proved to be highly significant in contributing to risk of in-hospital death following CEA. We used Ն3 Charlson comorbidities as the reference group, and compared the odds of death for patients with one or two comorbidities. After controlling for annual surgeon volume, hospital volume and age (Յ60 years versus Ͼ60 years), patients with only one Charlson comorbidity were found to have less than 20% of the odds of death compared with those with Ն3 comorbidities (odds ratio 0.187, P Ͻ .0001). Patients with two Charlson comorbidities had 0.362 the odds of death compared with the reference group (P Ͻ .0001). This confirms the need for careful patient selection for CEA.
The strengths of our study lie in its unique approach compared with previous analyses of the volume-outcome effect. We examined the data by inspection of logittransformed lowess smoothing functions for appropriate cutoffs rather than using quantiles or empiric volume categories. By using the data itself to choose volume categories, we avoided "fishing" for cutoffs rendering the lowest P values, instead choosing the best combination of knots based on log-likelihoods.
The weaknesses of our study mirror those with the use of any secondary analysis of administrative data. We believe the data source to be valid, based on previous corroboration with our institution's CEA data. 29 Nonetheless, as with any administrative dataset, there is the potential for non-differential or differential underreporting of events. Non-differential underreporting would bias our findings towards the null, whereas systematic, differential underreporting could change the direction or magnitude of the effect. Another threat to internal validity of administrative data includes confounding. 35 Our data lacks information on surgeon or hospital characteristics, which could act as unmeasured confounders in the relationship between CEA annual volume and in-hospital death. For instance, our data contains no information on specialty training, years in practice, or other factors that could contribute to technical expertise. The high number of surgeons performing a single CEA annually (214 unique practitioners over the 10-year study, or 48.4%) begs the question of whether these "surgeons" in fact represent referral physicians or trainees. We feel this is unlikely, given our requirement of the presence of Diagnosis Related Group 5 in our case identification algorithm. Given the ghost coding of physicians in the Maryland HSCRC database, it is not possible to know the board certification or fellowship training status of the providers and it therefore remains possible that some non-surgeons or trainees were captured in our analysis.
Additionally, although we used the HSCRC database for 10 years and identified 22,772 patients who underwent CEA, the database included only 123 deaths. This low number of events may have limited our ability to detect statistically significant differences. Our analysis is limited by the inability to differentiate deaths attributable directly to CEA from those related to underlying medical conditions. Some patients may have died from unrelated causes, such as pulmonary embolism or arrhythmia. The use of a more common complication such as post-CEA stroke would have provided a larger number of events and a more relevant volume-outcome relationship.
We chose to control for patient comorbidity using those conditions identified by Charlson because this method remains the most widely used, and has been validated in multiple languages and for other diseases. However, Elixhauser has developed a method with some strengths over the Charlson approach, by capturing acute illnesses, adding a number of comorbidities, and dropping others that seemed conceptually inappropriate. 36 We also did not use the weights included in the original Charlson Index, as we did not want to assume that these weights derived from Charlson's set of medical patients would apply to the surgical patients in our dataset. Of perhaps more relevance, the Maryland HSCRC database lacks presenton-admission coding. It is therefore possible that some comorbidities may in fact represent complications of the CEA itself. Despite these limitations, we feel that our approach remains a reasonable method to provide some measure of control over comorbidities in this study demonstrating a rigorous statistical treatment of the volumeoutcome effect. We elected to control for comorbidity rather than symptomatic status as methods for comorbidity adjustment are well-validated, whereas those for identification of symptomatic status are not. Previous work from our group has demonstrated that the overwhelming majority of patients undergoing CEA today in Maryland, as elsewhere, are asymptomatic. This is consistent with the preponderance of asymptomatic patients treated in most of the very recent carotid stent trials and registries.
We have demonstrated a technique for rigorous statistical analysis of volume-outcome data and have found a modest volume effect for death after CEA in this 10-year dataset from Maryland after controlling for patient comorbidities and age. Higher volume surgeons had lower estimated odds of death, particularly when considering those performing four to 15 CEAs per year. These data suggest that a patient undergoing CEA by a surgeon performing an average of 16 CEAs annually has a statistically equivalent risk of death compared with one undergoing CEA by a surgeon performing any number higher than this, when controlling for hospital volume, patient comorbidity, and patient age. Hospital volume was not seen to be as significant a predictor of post-operative death in this study, with only high volume hospitals (Ͼ130 CEAs per year) showing a statistically significant decrease in the estimated odds ratio of death. Patient comorbidity was a significant predictor of in-hospital post-operative death even after controlling for surgeon and hospital volume and patient age, confirming the need for careful patient selection for CEA. As studies on volume-outcome relationships can have important implications for health policy and surgical training, such studies should consider non-linear effects in their modeling of procedural volume. 
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